Novel anti-ITGA4 monoclonal antibody induces cell death via large pore formation in NK/T-cell lymphoma cells. [PDF]
Takeuchi S +20 more
europepmc +1 more source
Cucurbitacin B inhibits HIF-1α and attenuates non-small cell lung cancer <i>via</i> ZFP91. [PDF]
Song L +12 more
europepmc +1 more source
Cucurbitacin IIa Alleviates Colitis via Promoting the Release of Host-Derived Extracellular Vesicles Encapsulating microRNA-30b-5p. [PDF]
Zhao Y, Jiang B, Zuo S.
europepmc +1 more source
Cucurbitacin B Exhibits Antitumor Effects on Chordoma Cells via Disruption of Brachyury. [PDF]
Seeling C +7 more
europepmc +1 more source
Correction: Salehi et al. <i>Cucurbits</i> Plants: A Key Emphasis to Its Pharmacological Potential. <i>Molecules</i> 2019, <i>24</i>, 1854. [PDF]
Salehi B +23 more
europepmc +1 more source
Response of microbial communities and physical and chemical properties in inoculated soils with <i>Fusarium oxysporum</i> Schl. F. sp. <i>Benincasae</i> to different root exudates resistant to fusarium wilt. [PDF]
Wu H +6 more
europepmc +1 more source
Cucurbitacin B from Cucurbitaceae Plants: Treating Pancreatic Cancer via Inducing Mitophagy, Inhibiting Glycolysis, and Enhancing Immune Function. [PDF]
Yin D +10 more
europepmc +1 more source
Hu-lu-su-pian ameliorates hepatic steatosis by regulating CIDEA expression in AKT-driven MASLD mice. [PDF]
Ren R +10 more
europepmc +1 more source
Related searches:
Cucurbitacin B, a member of the cucurbitaceae family, can act as a STAT3 signaling inhibitor to regulate the growth of hepatocellular carcinoma. STAT3 signaling has been shown to inhibit adipocyte differentiation through C/EBPα and PPARγ. Based on these studies, we hypothesized that cucurbitacin B would prevent PPARγ mediated adipocyte differentiation ...
Dong Kwon Yang +2 more
exaly +3 more sources
Antiangiogenic effects of cucurbitacin-I
Archives of Pharmacal Research, 2014Cucurbitacin-I is a naturally occurring tetracyclic triterpenoid compound with diverse physiological actions that include inducing apoptosis and blocking cell cycle progression of various cancer cells. However, its antiangiogenic activity has not yet been examined.
Jin-Kyung Kim
exaly +3 more sources

